Bessemer Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8K | Buy |
67
+51
| +319% | +$6.09K | ﹤0.01% | 1896 |
|
|
2025
Q1 | $2K | Sell |
16
-22
| -58% | -$2.75K | ﹤0.01% | 2247 |
|
|
2024
Q4 | $4K | Buy |
+38
| New | +$4K | ﹤0.01% | 2072 |
|
|
2023
Q3 | – | Sell |
-17
| Closed | -$1K | – | 2255 |
|
|
2023
Q2 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 2173 |
|
|
2020
Q3 | – | Sell |
-21
| Closed | -$1K | – | 1529 |
|
|
2020
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 1670 |
|
|
2020
Q1 | $1K | Sell |
21
-3
| -13% | -$143 | ﹤0.01% | 1580 |
|
|
2019
Q4 | $1K | Buy |
24
+2
| +9% | +$83 | ﹤0.01% | 1593 |
|
|
2019
Q3 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 1660 |
|
|
2019
Q2 | – | Sell |
-24
| Closed | -$2K | – | 1759 |
|
|
2019
Q1 | $2K | Sell |
24
-10,508
| -100% | -$876K | ﹤0.01% | 1677 |
|
|
2018
Q4 | $891K | Buy |
10,532
+627
| +6% | +$53K | ﹤0.01% | 602 |
|
|
2018
Q3 | $1.7M | Buy |
9,905
+287
| +3% | +$49.1K | 0.01% | 453 |
|
|
2018
Q2 | $1.24M | Hold |
9,618
| – | – | ﹤0.01% | 521 |
|
|
2018
Q1 | $991K | Sell |
9,618
-321
| -3% | -$33.1K | ﹤0.01% | 584 |
|
|
2017
Q4 | $849K | Buy |
9,939
+4,135
| +71% | +$353K | ﹤0.01% | 655 |
|
|
2017
Q3 | $493K | Buy |
5,804
+5,770
| +16,971% | +$490K | ﹤0.01% | 853 |
|
|
2017
Q2 | $3K | Hold |
34
| – | – | ﹤0.01% | 1724 |
|
|
2017
Q1 | $2K | Sell |
34
-91
| -73% | -$5.35K | ﹤0.01% | 1680 |
|
|
2016
Q4 | $8K | Sell |
125
-8,759
| -99% | -$561K | ﹤0.01% | 1666 |
|
|
2016
Q3 | $565K | Buy |
8,884
+8,738
| +5,985% | +$556K | ﹤0.01% | 747 |
|
|
2016
Q2 | $11K | Sell |
146
-122
| -46% | -$9.19K | ﹤0.01% | 1070 |
|
|
2016
Q1 | $18K | Sell |
268
-34,828
| -99% | -$2.34M | ﹤0.01% | 1076 |
|
|
2015
Q4 | $2.37M | Hold |
35,096
| – | – | 0.01% | 398 |
|
|
2015
Q3 | $1.88M | Buy |
35,096
+35,019
| +45,479% | +$1.87M | 0.01% | 433 |
|
|
2015
Q2 | $5K | Hold |
77
| – | – | ﹤0.01% | 1359 |
|
|
2015
Q1 | $4K | Buy |
+77
| New | +$4K | ﹤0.01% | 1374 |
|